Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mette S. van Ramshorst"'
Autor:
Inge Kemper, I.A.M. Mandjes, Agnes J. van de Wouw, Marie-Jeanne T. F. D. Vrancken Peeters, Aafke H. Honkoop, Anna van der Voort, Laurence J. C. van Warmerdam, Caroline M.P.W. Mandigers, Irma M. Oving, Annelie J. Vulink, Sabine C. Linn, Lidwine W. Tick, Mette S. van Ramshorst, Erik van Werkhoven, Jelle Wesseling, Gabe S. Sonke
Publikováno v:
Journal of Clinical Oncology. 38:501-501
501 Background: The multicenter phase III TRAIN-2 study showed high pathological complete response (pCR) rates after neoadjuvant chemotherapy with and without anthracylines plus dual HER2-blockade in stage II-III HER2-positive breast cancer patients
Autor:
Marie-Jeanne T. F. D. Vrancken Peeters, Jelle Wesseling, Mette S. van Ramshorst, Gabe S. Sonke, Emilie J. Groen, Claudette E. Loo, Gonneke Winter-Warnars, Frederieke van Duijnhoven
Publikováno v:
Breast cancer research and treatment. 164(1)
Neoadjuvant treatment of HER2-positive breast cancer frequently leads to a pathologic complete response (pCR), which is associated with favourable long-term outcome. Treatment regimens typically consist of 6-9 cycles of trastuzumab-based chemotherapy
Autor:
Suzana C Teixeira, Bas B. Koolen, Jelle Wesseling, Marie-Jeanne T. F. D. Vrancken Peeters, Emiel J. Th. Rutgers, Gabe S. Sonke, Sjoerd Rodenhuis, Renato A. Valdés Olmos, Mette S. van Ramshorst, Kenneth E. Pengel, Kenneth G. A. Gilhuijs, Wouter V. Vogel
Publikováno v:
Cancer Imaging, Vol 17, Iss 1, Pp 1-8 (2017)
Cancer imaging, 17(1). e-med
Cancer Imaging, 17(1). e-med
Cancer Imaging
Cancer imaging, 17(1). e-med
Cancer Imaging, 17(1). e-med
Cancer Imaging
Background 18F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast a
Autor:
Mette S. van Ramshorst, Sabine C. Linn, Gwen M. H. E. Dackus, Gabe S. Sonke, Margriet van der Heiden-van der Loo
Publikováno v:
Breast Cancer Research and Treatment. 159:393-393
In the original publication of the article, the P-value for two interactions tests was accidently swapped. Under the heading Overall survival, the sentence starting with “Also, for HR status no…… 0 .95)” should read as “Also, for HR status